FDAnews
www.fdanews.com/articles/145748-medivir-hep-c-drug-cures-80-percent-of-patients-post-treatment

Medivir Hep C Drug Cures 80 Percent of Patients Post-Treatment

April 19, 2012
Medivir’s experimental hepatitis C treatment TMC435 cured as many as 80 percent of patients 24 weeks after treatment ended, suggesting that the therapy prevents the virus from surging back.
Bloomberg